At the time of writing, Organogenesis Holdings Inc [ORGO] stock is trading at $3.34, up 0.30%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ORGO shares have gain 10.96% over the last week, with a monthly amount drifted -5.92%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Organogenesis Holdings Inc [NASDAQ: ORGO] stock has seen the most recent analyst activity on June 28, 2024, when Lake Street initiated its Buy rating and assigned the stock a price target of $5. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on February 07, 2024, and set its price target to $5. On June 15, 2023, Morgan Stanley initiated with a Equal-Weight rating and assigned a price target of $5 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $10 on May 24, 2023. BTIG Research downgraded its rating to a Neutral. Oppenheimer downgraded its rating to Perform for this stock on August 10, 2022. In a note dated January 10, 2020, SVB Leerink initiated an Outperform rating and provided a target price of $9 on this stock.
For the past year, the stock price of Organogenesis Holdings Inc fluctuated between $2.16 and $4.57. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Organogenesis Holdings Inc [NASDAQ: ORGO] shares were valued at $3.34 at the most recent close of the market. An investor can expect a potential return of 49.7% based on the average ORGO price forecast.
Analyzing the ORGO fundamentals
According to Organogenesis Holdings Inc [NASDAQ:ORGO], the company’s sales were 455.04M for trailing twelve months, which represents an 6.12% jump. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.29 points at the first support level, and at 3.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.39, and for the 2nd resistance point, it is at 3.44.
Ratios To Look Out For
It is important to note that Organogenesis Holdings Inc [NASDAQ:ORGO] has a current ratio of 3.09. Further, the Quick Ratio stands at 2.74, while the Cash Ratio is 1.22. Considering the valuation of this stock, the price to sales ratio is 0.92, the price to book ratio is 1.59.
Transactions by insiders
Recent insider trading involved Gillheeney Gary S., President and CEO, that happened on Dec 13 ’24 when 55615.0 shares were sold. President and CEO, Gillheeney Gary S. completed a deal on Dec 16 ’24 to sell 5585.0 shares. Meanwhile, President and CEO Gillheeney Gary S. sold 0.16 million shares on Dec 11 ’24.
